company background image
SNW2 logo

Sanofi DB:SNW2 Stock Report

Last Price

€43.40

Market Cap

€110.7b

7D

-0.5%

1Y

-8.8%

Updated

25 Mar, 2024

Data

Company Financials +

SNW2 Stock Overview

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

SNW2 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends5/6

Sanofi Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sanofi
Historical stock prices
Current Share Price€43.40
52 Week High€52.00
52 Week Low€40.40
Beta0.44
1 Month Change-2.69%
3 Month Change-1.81%
1 Year Change-8.82%
3 Year Change6.37%
5 Year Change11.86%
Change since IPO48.63%

Recent News & Updates

Recent updates

Shareholder Returns

SNW2DE PharmaceuticalsDE Market
7D-0.5%3.0%1.3%
1Y-8.8%-25.6%6.4%

Return vs Industry: SNW2 exceeded the German Pharmaceuticals industry which returned -25.6% over the past year.

Return vs Market: SNW2 underperformed the German Market which returned 6.4% over the past year.

Price Volatility

Is SNW2's price volatile compared to industry and market?
SNW2 volatility
SNW2 Average Weekly Movement2.4%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: SNW2 has not had significant price volatility in the past 3 months.

Volatility Over Time: SNW2's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197386,088Paul Hudsonhttps://www.sanofi.com

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.

Sanofi Fundamentals Summary

How do Sanofi's earnings and revenue compare to its market cap?
SNW2 fundamental statistics
Market cap€110.68b
Earnings (TTM)€5.40b
Revenue (TTM)€46.03b

20.5x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SNW2 income statement (TTM)
Revenue€46.03b
Cost of Revenue€14.22b
Gross Profit€31.82b
Other Expenses€26.42b
Earnings€5.40b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 25, 2024

Earnings per share (EPS)4.32
Gross Margin69.12%
Net Profit Margin11.73%
Debt/Equity Ratio22.0%

How did SNW2 perform over the long term?

See historical performance and comparison

Dividends

4.2%

Current Dividend Yield

87%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.